Betaferon Use in Children and Adolescents With Multiple Sclerosis

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

NCT03408093 ·Status: COMPLETED

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

NCT00313976 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT03958877 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

NCT00370071 ·Status: COMPLETED ·Phase: PHASE3

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

NCT01491100 ·Status: COMPLETED

Betaferon® Regulatory Post-Marketing Surveillance

NCT01414816 ·Status: COMPLETED

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

NCT01706055 ·Status: COMPLETED

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

NCT00928967 ·Status: COMPLETED

Interferon ß-1b Treatment by Cyclical Administration

NCT00270816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Rehabilitation Study in MS Patients

NCT00780455 ·Status: TERMINATED ·Phase: PHASE4

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657 ·Status: COMPLETED

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

NCT00185211 ·Status: COMPLETED ·Phase: PHASE3

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

NCT01071694 ·Status: WITHDRAWN

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

NCT01184833 ·Status: COMPLETED

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

NCT03134573 ·Status: COMPLETED

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

NCT01142518 ·Status: COMPLETED

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

NCT00235989 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis

NCT01142557 ·Status: COMPLETED

Physical Disability in Patients Treated With Betaferon

NCT00873340 ·Status: COMPLETED

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

NCT00461396 ·Status: COMPLETED

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

NCT01795872 ·Status: COMPLETED ·Phase: PHASE4

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

NCT01233245 ·Status: COMPLETED

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

NCT00099502 ·Status: COMPLETED ·Phase: PHASE3

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

NCT00459667 ·Status: COMPLETED ·Phase: PHASE3

BAY86-5046 (Betaseron), Non Interventional Studies

NCT02121444 ·Status: COMPLETED